LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes
Nobuyuki Hizawa Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan Abstract: In the combined use of bronchodilators of different classes, ie, long-acting β2-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs), bronchodilation...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-06-01
|
| Series: | International Journal of COPD |
| Online Access: | http://www.dovepress.com/lamalaba-vs-icslaba-in-the-treatment-of-copd-in-japan-based-on-the-dis-peer-reviewed-article-COPD |